Quantamental Technologies’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$750K Buy
+8,036
New +$906K 0.7% 28
2023
Q1
Sell
-2,477
Closed -$280K 474
2022
Q4
$280K Buy
+2,477
New +$272K 0.13% 278
2022
Q1
Sell
-2,872
Closed -$386K 422
2021
Q4
$386K Buy
+2,872
New +$413K 0.2% 202
2020
Q3
Sell
-8,988
Closed -$911K 287
2020
Q2
$911K Buy
+8,988
New +$804K 0.61% 50
2019
Q3
Sell
-1,104
Closed -$41K 1592
2019
Q2
$41K Sell
1,104
-2,520
-70% -$79.2K 0.02% 956
2019
Q1
$108K Buy
+3,624
New +$127K 0.05% 573

Other funds holding DXCM

Quantamental Technologies's DXCM Position: Q3 2023 in Review

Quantamental Technologies opened a new position in DexCom (DXCM) in Q3 2023: 8,036 shares worth $750K. The stake represents 0.7% of the portfolio and ranks #28 among its holdings. This is a return to the name: Quantamental Technologies previously reported a position in DXCM as recently as Q4 2022.

Quantamental Technologies first reported a position in DXCM in Q1 2019 and has held it in 6 quarters since. The position peaked at $911K in Q2 2020. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Quantamental Technologies held 8,036 shares of DexCom worth $750K as of Q3 2023.
  • DexCom was a new Quantamental Technologies position in Q3 2023.
  • DexCom made up 0.7% of Quantamental Technologies's portfolio in Q3 2023, its #28 holding.
  • Quantamental Technologies first reported a position in DexCom in Q1 2019 and has held it in 6 quarters since.
  • Quantamental Technologies's DexCom position peaked at $911K in Q2 2020.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.